Cited by 104Alzheimer's disease research and treatmentsBarrier Structure and Function StudiesNeuroinflammation and Neurodegeneration Mechanisms

Brain Endothelial Cells Synthesize Neurotoxic Thrombin in Alzheimer’s Disease

Open access
Yin, Xiangling, Wright, Jill, Wall, Trevor, Grammas, Paula·2010·The American Journal of Pathology

Abstract

Alzheimer's disease (AD) is characterized by neuronal death; thus, identifying neurotoxic proteins and their source is central to understanding and treating AD. The multifunctional protease thrombin is neurotoxic and found in AD senile plaques. The objective of this study was to determine whether brain endothelial cells can synthesize thrombin and thus be a source of this neurotoxin in AD brains. Microvessels were isolated from AD patient brains and from age-matched controls. Reverse transcription-PCR demonstrated that thrombin message was highly expressed in microvessels from AD brains but was not detectable in control vessels. Similarly, Western blot analysis of microvessels showed that the thrombin protein was highly expressed in AD- but not control-derived microvessels. In addition, high levels of thrombin were detected in cerebrospinal fluid obtained from AD but not control patients, and sections from AD brains showed reactivity to thrombin antibody in blood vessel walls but not in vessels from controls. Finally, we examined the ability of brain endothelial cells in culture to synthesize thrombin and showed that oxidative stress or cell signaling perturbations led to increased expression of thrombin mRNA in these cells. The results demonstrate, for the first time, that brain endothelial cells can synthesize thrombin, and suggest that novel therapeutics targeting vascular stabilization that prevent or decrease release of thrombin could prove useful in treating this neurodegenerative disease.

Integrity signals

Registry

Crossref · 10.2353/ajpath.2010.090406

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intracranial injection of thrombin activates microglia, leading to production of NO and TNFα via JAK2-STAT3 signaling pathway, which induce BBB disruption.

    “Furthermore, it was shown that intracranial injection of thrombin activates microglia, leading to the production of NO and TNFα via JAK2-STAT3 signaling pathway, which induce BBB disruption.”

    From The impact of microglial activation on blood-brain barrier in brain diseases (2014) · cites this paper as Yin et al., 2010

  • Thrombin causes disruption of the BBB indirectly by activation of microglia.

    “Thus, it appears that thrombin causes a disruption of BBB indirectly by activation of microglia (Huang et al., 2008a,b; Yin et al., 2010; Grammas, 2011).”

    From The impact of microglial activation on blood-brain barrier in brain diseases (2014) · cites this paper as Yin et al., 2010

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yin, X., Wright, J., Wall, T., & Grammas, P.
Affiliations
Texas Tech University (US)
Corresponding author
Grammas, Paula
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2010-04
Volume
176
Issue
4
Pages
1600-1606
ISSN
0002-9440 (ISSN-L)
OpenAlex
W2105503070
Cited by
104
References
72
Citations by year
2026: 3 · 2025: 3 · 2024: 6 · 2023: 6 · 2022: 5 · 2021: 7 · 2020: 8 · 2019: 10 · 2018: 3 · 2017: 3 · 2016: 9 · 2015: 6 · 2014: 10 · 2013: 8 · 2012: 3
FWCI
5.41
Type
journal article
Language
en
Open access
Locations
  • American Journal Of Pathology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute on Aging (AG 15964, AG-020569, AG028367, R01AG028367, R01AG020569, R01AG015964)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, thrombin, brain endothelial cells, neurotoxicity, cerebral microvasculature, amyloid plaques, cerebrospinal fluid, oxidative stress, vascular stabilization, neurodegeneration
MeSH terms
Aged, Alzheimer Disease, Animals, Brain, Disease Models, Animal, Humans, Microcirculation, Middle Aged, Neurotoxins, Thrombin, Signal Transduction, Neurodegenerative Diseases, Reverse Transcriptase Polymerase Chain Reaction, Endothelial Cells, Rats, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review